Skip to main content

Fidelity — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

258
Companies
$29.2B
Total invested
$175.8M
Avg. check
50
Industries
Biotechnology 10Health Care 7Therapeutics 5Finance 4Financial Services 4Biopharma 3+44 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 258
Everledger
July 2021

Everledger provides an immutable ledger for diamond and other asset ownership and related supply chain history.

Asset Management · London$2.2M Grant
City Therapeutics
June 2026

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

Biopharma · Cambridge$99.5M Series B
Cipher Mining
June 2026

Cipher Mining is an industrial-scale Bitcoin mining company dedicated to expanding and strengthening the Bitcoin network's infrastructure.

Bitcoin · Rye$810.0M Post-IPO Debt
Cyxtera Technologies
June 2023

Cyxtera Technologies provides an integrated, secure, and resilient infrastructure platform.

Analytics · Coral Gables$200.0M Post-IPO Debt
Shoulder Innovations
June 2026

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

Biotechnology · Holland$45.0M Post-IPO Debt
Nuvation Bio
June 2026

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Biotechnology · New York$250.0M Post-IPO Debt
Absci
June 2026

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Artificial Intelligence (AI) · Vancouver$100.0M Post-IPO Equity
Nearfield Instruments
June 2026

Nearfield Instruments develops and supplies metrology & inspection equipment for semiconductor manufacturing process control.

Electronics · Rotterdam$380.0M Series D
Starling Bank
June 2026

Starling Bank is a bank that offers personal, joint, and business accounts.

Banking · London$201.2M Debt Financing
Oddity
June 2025

Oddity is a consumer-tech company that builds and scales digital-first brands.

Beauty · New York$525.0M Post-IPO Debt
ASAPP
May 2026

ASAPP is the agentic Customer Experience Platform (CXP) purpose-built for enterprise customer service.

Agentic AI · New York$24.1M Debt Financing
Rush Street Interactive
May 2026

Rush Street Interactive offers online casino and sports betting in the U.S.

Casino · Chicago$26.0M Post-IPO Secondary
Allena Pharmaceuticals
May 2022

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Biotechnology · Newton$2.8M Post-IPO Equity
Editas Medicine
May 2026

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Biotechnology · Cambridge$125.0M Post-IPO Equity
ElevateBio
May 2023

ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.

Alternative Medicine · Waltham$401.0M Series D
P3 Health Partners
May 2024

P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.

Finance · Henderson$42.2M Post-IPO Equity
Osmoses
May 2025

Osmoses engages in decarbonizing gas separations to eliminate one gigaton of carbon emissions per year.

GreenTech · Cambridge$500K Grant
Smart
May 2023

Smart is a savings and investments technology platform provider.

Financial Services · London$95.0M Series E
Ikena Oncology
May 2023

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Biotechnology · Boston$40.0M Post-IPO Equity
CelLink
May 2023

High-conductance, large-area flexible circuits for the clean power revolution.

Electric Vehicle · San Carlos$362.0M Debt Financing
Tumelo
May 2022

Tumelo is an impact-focused financial technology firm with the mission of giving every investor a voice.

Finance · Bristol$18.8M Series A
Intellia Therapeutics
April 2026

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Biotechnology · Cambridge$180.0M Post-IPO Equity
Endeavor BioMedicines
April 2024

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

Biotechnology · Solana Beach$132.5M Series C
Prelude Therapeutics
April 2026

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Biopharma · Wilmington$90.0M Post-IPO Equity

Where Fidelity invests

Biotechnology10
Health Care7
Therapeutics5
Finance4
Financial Services4
Biopharma3

About Fidelity's portfolio

How many companies has Fidelity invested in?▸

Fidelity has invested in 258 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?▸

Fidelity's top investment sectors include Biotechnology, Health Care, Therapeutics, Finance, Financial Services. The firm invests across 50 different industry categories.

What is Fidelity's largest investment?▸

Among tracked funding rounds, Cipher Mining received $810.0M in a Post-IPO Debt round. Fidelity's total known invested capital is $29.2B.

What is the average investment size for Fidelity?▸

Fidelity's average investment size is $175.8M across its portfolio of 258 companies.

What are Fidelity's most recent investments?▸

Recent Fidelity portfolio additions include Everledger, City Therapeutics, Cipher Mining, Cyxtera Technologies, Shoulder Innovations. These companies were founded in 2020 or later.

Reach the founders behind these 258 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →